PATENT CLAIM ANALYSIS

Application Number: 16340666
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-07
Patent Classification: ["514", "254050"]

Abstract:
Provided are a new tubulin inhibitor and applications thereof, the tubulin inhibitor being a series of compounds based on substituted heterocyclic skeletons, targeting the colchicine binding sites of tubulin. The structure is: Formula (I), wherein: formula (A), n independently expresses an integer between 0 and 5, the condition being that n≤5, A represents mono- or poly-substituted groups, the groups being selected from the group consisting of H, C1-C20 amide group, C1-C20 acyloxy group, C1-C20 alkanoyl group, C1-C20 alkoxycarbonyl group, C1-C20 alkoxy group, C1-C20 alkylamino group, C1-C20 alkylcarboxyamino group, aroyl group, aralkanoyl group, carboxyl group, cyano group, halogen group, hydroxyl group, nitro group and methylthienyl group.

Claim (Index 8):
Use of the compound of  claim 1  in combination with a chemotherapeutic agent for the manufacture of medicaments for the treatment of tumors.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 100.0
- Lexical Diversity: 1.83562
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15579429', '10499177', '10301871', '12412837', '14711911']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7395709008872935
- 35 USC 102 Novelty (BERT): 0.5468685924375222
- Combined Prediction Score: 0.7203006700423165
- Mean Citation Score: 268.43754
- Max Citation Score: 382.0325
- Similarity Product: 258.734025990963

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test